Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
R-MINE regimen
Introduction
Synonyms and keywords: Rituximab-Mesna-Ifosfamide-Novantrone-Etoposide regimen
Overview
Overview
R-MINE regimen refers to a regimen consisting of rituximab, mesna, ifosfamide, mitoxantrone, and etoposide used to treat relapsed or refractory Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.[1][2]
Regimen
Regimen
RRituximab
MMesna
IIfosfamide
NMitoxantrone (Novantrone)
EEtoposide
References
References
- ↑ 1.0 1.1 Fan Y, Huang ZY, Luo LH, Yu HF (2005). “[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin’s lymphoma]”. Ai Zheng. 24 (12): 1503–6. PMID 16351801.
- ↑ “NCI Thesaurus”.
- ↑ “NCI Thesaurus”.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]